109 related articles for article (PubMed ID: 25788388)
1. Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma.
Yashima Y; Sato S; Kawai T; Sugimoto T; Sato T; Kanda M; Obi S
Hepatol Int; 2015 Jan; 9(1):142-8. PubMed ID: 25788388
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon α-2b for advanced intrahepatic cholangiocarcinoma.
Kasai K; Kooka Y; Suzuki Y; Suzuki A; Oikawa T; Ushio A; Kasai Y; Sawara K; Miyamoto Y; Oikawa K; Takikawa Y
Ann Surg Oncol; 2014 Oct; 21(11):3638-45. PubMed ID: 24817369
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer.
Patt YZ; Jones DV; Hoque A; Lozano R; Markowitz A; Raijman I; Lynch P; Charnsangavej C
J Clin Oncol; 1996 Aug; 14(8):2311-5. PubMed ID: 8708722
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience.
Knox JJ; Hedley D; Oza A; Siu LL; Pond GR; Moore MJ
Ann Oncol; 2004 May; 15(5):770-4. PubMed ID: 15111345
[TBL] [Abstract][Full Text] [Related]
7. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion.
Kasai K; Ushio A; Kasai Y; Sawara K; Miyamoto Y; Oikawa K; Kuroda H; Takikawa Y; Suzuki K
Cancer; 2012 Jul; 118(13):3302-10. PubMed ID: 22072099
[TBL] [Abstract][Full Text] [Related]
9. Time to move to targeted drugs in biliary tract cancer?
Louvet C; Tournigand C
Onkologie; 2010; 33(1-2):10-1. PubMed ID: 20164655
[No Abstract] [Full Text] [Related]
10. A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.
Iqbal S; Rankin C; Lenz HJ; Gold PJ; Ahmad SA; El-Khoueiry AB; Messino MJ; Holcombe RF; Blanke CD
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1595-602. PubMed ID: 21556747
[TBL] [Abstract][Full Text] [Related]
11. Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma--initial experience.
Tanaka N; Yamakado K; Nakatsuka A; Fujii A; Matsumura K; Takeda K
Eur J Radiol; 2002 Jan; 41(1):42-8. PubMed ID: 11750151
[TBL] [Abstract][Full Text] [Related]
12. FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma.
Guion-Dusserre JF; Lorgis V; Vincent J; Bengrine L; Ghiringhelli F
World J Gastroenterol; 2015 Feb; 21(7):2096-101. PubMed ID: 25717243
[TBL] [Abstract][Full Text] [Related]
13. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
[TBL] [Abstract][Full Text] [Related]
14. Arterial infusion of 5-fluorouracil combined with subcutaneous injection of pegylated interferon alpha-2b in treating unresectable hepatocellular carcinoma with portal vein tumor thrombus.
Wu J; Huang WJ; Wang HY; Wang YF; Peng BG; Zhou Q
Med Oncol; 2015 Mar; 32(3):65. PubMed ID: 25691293
[TBL] [Abstract][Full Text] [Related]
15. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma.
Uka K; Aikata H; Takaki S; Miki D; Kawaoka T; Jeong SC; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol; 2007 Oct; 42(10):845-53. PubMed ID: 17940838
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment for advanced hepatocellular carcinoma with portal venous invasion using a combination therapy of intra-arterial 5-fluorouracil and subcutaneous pegylated-interferon-alpha-2b.
Mawatari H; Kirikoshi H; Yoneda M; Higurashi T; Fujita K; Saito S; Inamori M; Takahashi H; Abe Y; Kubota K; Nakajima A
Hepatogastroenterology; 2008; 55(86-87):1776-7. PubMed ID: 19102391
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report].
Wada H; Nagano H; Dono K; Kondo M; Yamamoto T; Ota H; Nakamura M; Yoshioka S; Damdinsuren B; Yubo Y; Marubashi S; Miyamoto A; Umeshita K; Nakamori S; Sakon M; Monden M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1711-3. PubMed ID: 15553691
[TBL] [Abstract][Full Text] [Related]
19. Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma.
Smith GW; Bukowski RM; Hewlett JS; Groppe CW
Cancer; 1984 Oct; 54(8):1513-6. PubMed ID: 6089991
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial infusion chemotherapy in combination with pegylated interferon-α-2b for advanced hepatocellular carcinoma.
Okita K; Yamasaki T; Hamabe S; Saeki I; Harima Y; Terai S; Sakaida I
Hepatogastroenterology; 2012; 59(114):533-7. PubMed ID: 22353519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
